RHOA and breast carcinoma: RhoA-directed siRNA exerted extraordinary tumor volume inhibitory effects (85% of tumor volume) in breast cancer, whereas when it was given with chitosan the tumor volume reduction was increased to 90% (to completely abolishing) for the higher dose.